Condition

GVHD clinical trials and research

• 8Clinical trials
• 4Countries

Newest GVHD clinical trials

All recruiting trials (8)

• How iNKT immune cells after allogeneic stem cell transplant relate to transplant complications

  This study tests whether levels of invariant NKT cells in the blood after an allogeneic stem cell transplant can be linked to complications like GvHD, infections, or relapse in patients with AML.

  Recruiting University Hospital Pilsen · Pilsen, Czechia · NCT07570407

• Psychiatric Symptoms and Quality of Life in Graft-versus-Host Disease

  This project will see if psychiatric symptoms like depression are linked to GvHD symptom severity and health-related quality of life in adults with graft-versus-host disease.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07314892

• Early Tacrolimus Taper After Allogeneic Transplant

  This study tests whether stopping tacrolimus early after an allogeneic stem cell transplant is safe and feasible for people with AML, MDS, MF, CML, CMML, or GVHD risk after transplant.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT07302776

• Vorinostat to help prevent GVHD in young people with non-malignant conditions undergoing stem cell transplant

  This phase 2 study tests whether adding vorinostat to standard GVHD prevention can reduce GVHD after stem cell transplant in patients aged 1–26 with non-malignant disorders.

  Recruiting Phase 2 University of Michigan · Ann Arbor, Michigan · NCT06995521

• Improving Bone Marrow Transplant Outcomes with Educational Sleep Intervention

  This study is testing whether an educational program about sleep can help adults getting a bone marrow transplant feel better compared to just the usual care they receive.

  Recruiting Scripps Health · San Diego, California · NCT06590285

• Preventing GvHD in patients with blood cancers undergoing stem cell transplants

  This study is testing a new treatment called TRX-103 to see if it can help prevent graft-versus-host disease in people with blood cancers who are getting stem cell transplants from mismatched donors.

  Recruiting at 5 sites Phase 1 Tr1X, Inc. · Duarte, California and 4 other locations · NCT06462365

• GVHD prevention with Thymoglobulin versus Grafalon in older adults with AML or MDS receiving a 10/10 matched unrelated donor transplant

  This trial tests whether Thymoglobulin or Grafalon better prevents graft-versus-host disease in people aged 50–70 with AML or MDS who are receiving a 10/10 HLA matched unrelated donor stem cell transplant.

  Recruiting at 26 sites Phase 3 Assistance Publique - Hôpitaux de Paris · Amiens and 27 other locations · NCT06083129

• Using light therapy to treat oral Graft-Versus-Host Disease after stem cell transplant

  This study tests if a special light therapy can help people with oral Graft-Versus-Host Disease after a stem cell transplant feel better when other treatments haven't worked.

  Recruiting at 9 sites Phase 2 Memorial Sloan Kettering Cancer Center · Bethesda, Maryland and 8 other locations · NCT05675930

Related topics

Quick answers

How many GVHD clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), Czechia (1 trial), France (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →